GSK

GSK’s Arexvy Gets European Commission Green Light For RSV Vaccination In Adults 18+

GSK’s Arexvy Gets European Commission Green Light For RSV Vaccination In Adults 18+

28 Jan 2026

2 min read

GSK’s Ellipta Secures China’s NMPA Approval For Adults With Uncontrolled Asthma

GSK’s Ellipta Secures China’s NMPA Approval For Adults With Uncontrolled Asthma

24 Jan 2026

2 min read

GSK’s Exdensur (depemokimab) Secures Japanese Regulatory Green Light For Severe Asthma & Chronic Rhinosinusitis Treatment

GSK’s Exdensur (depemokimab) Secures Japanese Regulatory Green Light For Severe Asthma & Chronic Rhinosinusitis Treatment

07 Jan 2026

2 min read

Read More

Voice Of HealthCare

vohnetwork.com